Francois Bertelli

VP Adc Development at Disco Pharmaceuticals Gmbh @Disco Pharmaceuticals Gmbh

Canterbury, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jun 2025 — Present

VP Adc Development at Disco Pharmaceuticals Gmbh @Disco Pharmaceuticals Gmbh

View department →

Cologne, DE

ADC Research and Development

EDUCATION

1993 — 1997

Paris-Sud University (Paris XI)

Ph.D., Enzymology, Physico-chemistry and Protein production

1993 — 1994

Universite Paris-Sud Orsay

Diplome d'Etudes Appronfondies DEA, Enzymology; Chemistry and Protein Engineering, Laboratory

1989 — 1991

Université Paris Cité

Licence/Maitrise, Biochemistry

1989 — 1991

the University of Sciences Paris 7 Jussieu

M. Sc; degree, Biochemistry

SKILLS

CellDrug DiscoveryMonoclonal AntibodiesPurificationAssay DevelopmentBiochemistryHtsGpcrsAntibodiesLaboratory AutomationProject Portfolio ManagementClinical DevelopmentMedicinal ChemistryCell Based AssaysLead ChangeProject CoordinationProtein CharaterizationPharmacologyCell CultureBiomarkersHigh Throughput ScreeningCustomer Focus

ABOUT FRANCOIS BERTELLI

Expert in antibody drug conjugates (ADC) and bispecifics design, molecular modelling, production and characterisation. Pre-clinical in vitro/in vivo project management for mAbs, ADCs, Bispecifics, and T-cell recruitment in Oncology and Immuno-Oncology. Antibody format generation and humanisation, Antigen cloning, expression, purification and characterisation (All analytical methods and Biacore kinetics determination). CMC Management of upstream and downstream Process Characterisation and Validation of Antibody/Antigen (Mammalian Cell culture and Fermentation) for manufacturing using cGMP methods. Work closely with CRO/CMOs for process development.As part of the Technical Operations team for Rare Reagents production and purification, I evaluate and improve the processes for large-scale protein production such as Monoclonal antibodies (Hollow-fiber, perfusion, wavebags, spinners) and the purification processes (Chromatography, Ultrafiltration, Dialysis, TFF).Supporting the Process Validation projects, making sure that activities are compliant with QMS and external guidelines (FDA & EU).* Facilitate risk assessment/FMEA process.* Perform QMS maintenance activities and implement quality improvement activities.* Assures the accuracy and correctness of documentation used during process validation activities.* Provide GMP guidance.15 years experience in Assay Development and High-Throughput-Screening Project Management. I have a track record in prosecution of drug discovery programmes from idea to candidate nomination, across broad disease, target and physiological systems. I have experience of both leading teams directly and indirectly through matrix-based disciplinesBroad knowledge of most of the therapeutic areas for which several HTS campaigns have been run successfully. I have received the project management foundation certficate PRINCE2.Specialties: Pharmacology, Enzymology, Cell-based assays, kinase and Protein-Protein Interaction assays. Project Management Drug Discovery. Protein Charaterisation.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Francois Bertelli — VP Adc Development at Disco Pharmaceuticals Gmbh at Disco Pharmaceuticals Gmbh in Canterbury, GB | Unifers